Form D · Biotechnology
Cellphire, Inc.
Rockville, MD · CIK 0001815181
Offering snapshot reported Dec 11, 2025 · SEC filing
- Reported sold
- $3M Offering amount: $3M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $17.7K Reported outside-investor minimum
- First sale
- Nov 26, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 11, 2025 | Initial | $3,000,000 | No comparison | 19 | SEC filing |
| Oct 3, 2023 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-566464
Source: Form D, filed Dec 11, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pamela Conley | Director |
| Thomas Dubin | Director |
| Michael Gaffney | Director, Executive |
| David Hirsh | Director |
| Angela Howerton | Executive |
| Rafael Jorda | Director |
| James Peake | Director |
| Randall Stanicky | Director |
| Cristiane Wolfe | Executive |
| Derek Woods | Director |
| Rob Woods | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9430 Key West Avenue, Suite 250
Rockville, MD, 20850
Rockville, MD, 20850